Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome
Authors:
Open Access
- 5 January 2016
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 47 (2) , 177-183
Abstract
Objectives: To evaluate the performance of a single‐nucleotide polymorphism (SNP)‐based non‐invasive prenatal test (NIPT) for the detection of fetal 22q11.2 deletion syndrome in clinical practice, assess clinical follow‐up and review patient choices for women with high‐risk results.Methods: In this study, 21 948 samples were submitted for screening for 22q11.2 deletion syndrome using a SNP‐based NIPT and subsequently evaluated. Follow‐up was conducted for all cases with a high‐risk result.Results: Ninety‐five cases were reported as high risk for fetal 22q11.2 deletion. Diagnostic testing results were available for 61 (64.2%) cases, which confirmed 11 (18.0%) true positives and identified 50 (82.0%) false positives, resulting in a positive predictive value (PPV) of 18.0%. Information regarding invasive testing was available for 84 (88.4%) high‐risk cases: 57.1% (48/84) had invasive testing and 42.9% (36/84) did not. Ultrasound anomalies were present in 81.8% of true‐positive and 18.0% of false‐positive cases. Two additional cases were high risk for a maternal 22q11.2 deletion; one was confirmed by diagnostic testing and one had a positive family history. There were three pregnancy terminations related to screening results of 22q11.2 deletion, two of which were confirmed as true positive by invasive testing.Conclusions: Clinical experience with this SNP‐based non‐invasive screening test for 22q11.2 deletion syndrome indicates that these deletions have a frequency of approximately 1 in 1000 in the referral population with most identifiable through this test. Use of this screening method requires the availability of counseling and other management resources for high‐risk pregnancies. © 2015 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd. on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.Keywords
This publication has 25 references indexed in Scilit:
- Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive valueAmerican Journal of Obstetrics and Gynecology, 2015
- Cell‐free DNA testing: inadequate implementation of an outstanding techniqueUltrasound in Obstetrics & Gynecology, 2015
- Fetal phenotype associated with the 22q11 deletionAmerican Journal of Medical Genetics Part A, 2014
- Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk CohortObstetrics & Gynecology, 2014
- Association of Copy Number Variants With Specific Ultrasonographically Detected Fetal AnomaliesObstetrics & Gynecology, 2014
- Prenatal Detection of Fetal Triploidy from Cell-Free DNA Testing in Maternal BloodFetal Diagnosis and Therapy, 2013
- SNP‐based non‐invasive prenatal testing detects sex chromosome aneuploidies with high accuracyPrenatal Diagnosis, 2013
- Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and YPrenatal Diagnosis, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)Medicine, 2011